ICD-10-CM Billable Code

D3A.024

Benign carcinoid tumor of the descending colon

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the descending colon is a type of slow-growing, non-cancerous tumor that originates from neuroendocrine cells within the colon. These tumors are generally considered less aggressive than malignant forms but require medical attention to monitor and manage their presence. The descending colon is part of the large intestine that helps in water absorption and stool formation.

Causes & Symptoms

Clinical Causes: Development from neuroendocrine cells in the colon lining Genetic factors that may predispose individuals to tumor growth Environmental influences such as exposure to certain chemicals or toxins Age-related changes, with higher incidence in middle-aged and older adults Rarely, underlying genetic syndromes like multiple endocrine neoplasia (MEN)

Key Symptoms: Often asymptomatic in early stages Changes in bowel habits, such as diarrhea or constipation Abdominal discomfort or pain Feeling of fullness or bloating Occasional bleeding leading to anemia or visible blood in stool Unintended weight loss in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of medical imaging and tissue sampling. Common procedures include colonoscopy, where the tumor can be visually inspected and biopsied, and imaging tests such as CT scans or MRI to determine the tumor's size, location, and any potential spread. Histopathological analysis of the biopsy confirms the benign nature of the tumor and its neuroendocrine origin.

Treatment Protocols: Management strategies often depend on the size and location of the tumor. Primary treatment usually involves surgical removal of the tumor through minimally invasive procedures or open surgery. Regular follow-up is essential to monitor for recurrence or changes in the tumor's characteristics. In some cases, surveillance may be sufficient if the tumor is small and asymptomatic, with intervention reserved for symptomatic or enlarging tumors.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.024 a billable ICD-10 code?
Yes, D3A.024 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.024?
Clinical documentation must specify the nature of Benign carcinoid tumor of the descending colon and any associated comorbidities for accurate reporting.

Cite this Clinical Reference